These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 9123201)

  • 1. Immunomodulation with intrathymic injection of donor splenocytes followed by CTLA4Ig therapy prolongs small intestinal allograft survival.
    Greenstein SM; Sun S; Schechner RS; Tellis VA
    Transplant Proc; 1997; 29(1-2):1065-6. PubMed ID: 9123201
    [No Abstract]   [Full Text] [Related]  

  • 2. Review of CTLA4Ig use for allograft immunosuppression.
    Lin H; Wei RQ; Gordon D; Linsley P; Turka LA; Bolling SF
    Transplant Proc; 1994 Dec; 26(6):3200-1. PubMed ID: 7998114
    [No Abstract]   [Full Text] [Related]  

  • 3. Prolonged small bowel allograft survival following repeated intrathymic injections of donor splenocytes and peripheral anti-lymphocyte treatment.
    Sun S; Greenstein SM; Schechner RS; Tellis VA
    Transplant Proc; 1999; 31(1-2):588-9. PubMed ID: 10083249
    [No Abstract]   [Full Text] [Related]  

  • 4. Donor intrathymic injection with recipient splenocytes allows indefinite survival following small bowel transplantation in a rat graft-vs-host disease model.
    Blakely ML; Shaffer D; Ohzato H; Gottschalk R; Van der Werf WJ; Monaco AP
    Transplant Proc; 1994 Jun; 26(3):1582. PubMed ID: 8030046
    [No Abstract]   [Full Text] [Related]  

  • 5. Prolongation of rat small bowel allograft survival by CTLA-4 IG.
    Tarumi K; Yagihashi A; Murakami M; Uede T; Hirata K
    Transplant Proc; 1998 Sep; 30(6):2596-9. PubMed ID: 9745507
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion.
    Lin H; Bolling SF; Linsley PS; Wei RQ; Gordon D; Thompson CB; Turka LA
    J Exp Med; 1993 Nov; 178(5):1801-6. PubMed ID: 8228826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerance for graft-versus-host disease by intrathymic injection of recipient-type splenocytes into donor.
    Vaidya S; Wang CC; Roorda C; Billings A; Rajaraman S; Fish JC
    Transplant Proc; 1997; 29(1-2):1073-5. PubMed ID: 9123205
    [No Abstract]   [Full Text] [Related]  

  • 8. CD28-B7 T-cell co-stimulatory blockade potentiates the effects of intrathymic immunomodulation in sensitized graft recipients.
    Stadlbauer TH; Schaub M; Korom S; Onodera K; Sayegh MH; Kupiec-Weglinski JW
    Transplantation; 1997 Dec; 64(12):1816-22. PubMed ID: 9422425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction and maintenance of tolerance by CTLA-4IG in rat small bowel allografts.
    Tarumi K; Yagihashi A; Tsuruma T; Koide S; Sasaki K; Hirata K
    Transplant Proc; 1999; 31(1-2):878-81. PubMed ID: 10083385
    [No Abstract]   [Full Text] [Related]  

  • 10. Feasibility of immunosuppression in composite tissue allografts by systemic administration of CTLA4Ig.
    Iwasaki N; Gohda T; Yoshioka C; Murakami M; Inobe M; Minami A; Uede T
    Transplantation; 2002 Feb; 73(3):334-40. PubMed ID: 11884927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD28 blockade alters cytokine mRNA profiles in cardiac transplantation.
    Lin H; Wei RQ; Goodman RE; Bolling SF
    Surgery; 1997 Aug; 122(2):129-37. PubMed ID: 9288115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged rat cardiac allograft survival using adenoviral vector containing the CTLA4Ig gene.
    Kita Y; Li XK; Hayashi S; Funeshima N; Enosawa S; Tamura A; Suzuki K; Kazui T; Amemiya H; Suzuki S
    Transplant Proc; 1998 Jun; 30(4):1079-80. PubMed ID: 9636437
    [No Abstract]   [Full Text] [Related]  

  • 13. A second intrathymic injection of donor splenocytes improves survival of small bowel allografts.
    Sun S; Greenstein SM; Kim DY; Schreiber TC; Schechner RS; Tellis VA
    Transplant Proc; 1998 Sep; 30(6):2575-6. PubMed ID: 9745495
    [No Abstract]   [Full Text] [Related]  

  • 14. CD28-pathway blockade with CTLA4Ig leads to prolongation of small bowel transplant survival in rats.
    Pescovitz MD; Yang R; Liu Q; Collins MH; Grosfeld JL
    Transplant Proc; 1994 Jun; 26(3):1618-9. PubMed ID: 8030059
    [No Abstract]   [Full Text] [Related]  

  • 15. Adenoviral vectors containing the CTLA4IG-gene inhibit chronic rejection in heterotopically transplanted rat tracheas.
    Kita Y; Li XK; Ohba M; Funeshima N; Enosawa S; Nogimura H; Ohi S; Kageyama Y; Matsushita K; Ito Y; Takahashi T; Suzuki K; Suzuki S; Kazui T
    Transplant Proc; 2000 Nov; 32(7):2036-7. PubMed ID: 11120055
    [No Abstract]   [Full Text] [Related]  

  • 16. CTLA-4IG treatment induces long-term acceptance of rat small bowel allografts.
    Tarumi K; Yagihashi A; Tsuruma T; Araya J; Hirata K
    Transplant Proc; 2000 Nov; 32(7):2028-31. PubMed ID: 11120051
    [No Abstract]   [Full Text] [Related]  

  • 17. Administration of CTLA4-Ig enhances the incidence of hamster-to-rat xenogeneic bone marrow engraftment and alters the presentation of graft-vs-host disease.
    Lee YH; Miki T; Kuddus R; Tandin A; Goller AL; Subbotin V; Fung JJ; Peach R; Valdivia LA; Rao AS
    Transplant Proc; 2000 Aug; 32(5):1032-3. PubMed ID: 10936336
    [No Abstract]   [Full Text] [Related]  

  • 18. CTLA4-Ig treatment prolongs rat orthotopic liver graft survival.
    Tu Y; Rehman A; Flye MW
    Transplant Proc; 1997; 29(1-2):1036-7. PubMed ID: 9123186
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunomodulation of intestinal transplant with allograft irradiation and simultaneous donor bone marrow infusion.
    Murase N; Ye Q; Lee RG; Demetris AJ; Abu-Elmagd K; Reyes J; Starzl TE
    Transplant Proc; 1999; 31(1-2):565-6. PubMed ID: 10083238
    [No Abstract]   [Full Text] [Related]  

  • 20. Indefinite survival following small intestinal transplantation after intrathymic injection of the donor with recipient-type splenocytes in a rat model.
    Blakely ML; Shaffer D; Ohzato H; Gottschalk R; Van der Werf WJ; Monaco AP
    Transplantation; 1995 Jan; 59(2):309-11. PubMed ID: 7839457
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.